Home | About us | Editorial Board | Search | Ahead of print | Current Issue | Archives | Instructions | Online submissionContact Us   |  Subscribe   |  Advertise   |  Login  Page layout
Wide layoutNarrow layoutFull screen layout
Lung India Official publication of Indian Chest Society  
  Users Online: 1543   Home Print this page  Email this page Small font size Default font size Increase font size
Year : 1982  |  Volume : 1  |  Issue : 2  |  Page : 13-17

Intermittent Rifampicin In Management Of Pulmonary Tuberculosis Under Programme Conditions

Correspondence Address:
A. G Patel

Login to access the Email id

Source of Support: None, Conflict of Interest: None

Rights and PermissionsRights and Permissions

Experience from Baroda (Gujarat State) of studies on different groups of tuberculous patients treated with conventional drugs along with intermittent rifampicin exhibited for durations ranging from 13 to 24 weeks under programme conditions, forms the subject matter of this report. The paper deals with five different studies where twice or once a week rifampicin containing regimens, are found to be 100% effective. In the experience of the author, patient's compliance seems to be relatively high in his part of the country compared to the service programme operating in other areas. Adverse reactions, of an immunological nature to rifampicin, are found to be less than 1% in these series of patients and the total cost is not more than conventional 12-18 months therapy with standard drugs. Relapses appear to be few when patients in the first two studies were followed up over a period of two and a half to four years.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded104    
    Comments [Add]    

Recommend this journal